請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/76504
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 蕭妃秀(Fei-Hsiu Hsiao) | |
dc.contributor.author | Chiau-Mei Huang | en |
dc.contributor.author | 黃僑眉 | zh_TW |
dc.date.accessioned | 2021-07-09T15:53:24Z | - |
dc.date.available | 2022-08-28 | |
dc.date.copyright | 2019-08-28 | |
dc.date.issued | 2019 | |
dc.date.submitted | 2019-08-14 | |
dc.identifier.citation | 賴玉玫、徐紹勛。(2017) 肺高壓的診斷與治療準則. 臺北市: 肺病防治基金會.
盧孟良、車先蕙、張尚文、沈武典。(2002) 中文版貝克憂鬱量表第二版之信度和效度。台灣精神醫學, 16(4):301-310。 謝佳真。(2011) 比較婦癌存活者與健康婦女之生活品質及其影響因素. 臺灣大學護理學研究所學位論文, 1-91. 張仁和、林以正、黃金蘭 (民100)。中文版[止觀覺察注意量表] 之信效度分析. 測驗學刊專刊---正向心理特質的測量,235-260。 陳寀羚、周汎澔、王秀紅 (民105)。正念之概念分析 [Mindfulness: A Concept Analysis]。護理雜誌,63(2),113-119。doi:10.6224/jn.63.2.113 Aguirre-Camacho, A., & Moreno-Jimenez, B. (2018). Depression and Anxiety in Patients With Pulmonary Hypertension: The Role of Life Satisfaction and Optimism. Psychosomatics, 59(6), 575-583. doi:10.1016/j.psym.2018.04.002 Badesch, D. B., Raskob, G. E., Elliott, C. G., Krichman, A. M., Farber, H. W., Frost, A. E., . . . McGoon, M. D. (2010). Pulmonary Arterial Hypertension: Baseline Characteristics From the REVEAL Registry. Chest, 137(2), 376-387. doi:https://doi.org/10.1378/chest.09-1140 Barnett, C. F., Alvarez, P., & Park, M. H. (2016). Pulmonary Arterial Hypertension: Diagnosis and Treatment. Cardiol Clin, 34(3), 375-389. doi:https://doi.org/10.1016/j.ccl.2016.04.006 Batal, O., Khatib, O. F., Bair, N., Aboussouan, L. S., & Minai, O. A. (2011). Sleep Quality, Depression, and Quality of Life in Patients with Pulmonary Hypertension. Lung, 189(2), 141-149. doi:10.1007/s00408-010-9277-9 Beck, A. T., Ward, C. H., Mendelson, M., Mock, J., & Erbaugh, J. (1961). An inventory for measuring depression. Arch Gen Psychiatry, 4, 561-571. Bifulco, A., Moran, P. M., Ball, C., & Bernazzani, O. (2002). Adult attachment style. I: Its relationship to clinical depression. Social Psychiatry and Psychiatric Epidemiology, 37(2), 50-59. doi:10.1007/s127-002-8215-0 Chang, W. T., Weng, S. F., Hsu, C. H., Shih, J. Y., Wang, J. J., Wu, C. Y., & Chen, Z. C. (2016). Prognostic Factors in Patients With Pulmonary Hypertension—A Nationwide Cohort Study. Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 5(9), e003579. doi:10.1161/JAHA.116.003579 Chiang, Y. C., Hu, L. Y., Couper, J., Cheng, C. C., Huang, W. C., & Lu, T. (2018). EXPRESS: Exploring the Experiences and Psychosocial Stresses of Taiwanese Patients with Pulmonary Hypertension: A Qualitative Interview Study. Pulm Circ, 2045894018787479. doi:10.1177/2045894018787479 Chin, K., & Channick, R. N. (2016). 58 - Pulmonary Hypertension A2 - Broaddus, V. Courtney. In R. J. Mason, J. D. Ernst, T. E. King, S. C. Lazarus, J. F. Murray, J. A. Nadel, A. S. Slutsky, & M. B. Gotway (Eds.), Murray and Nadel's Textbook of Respiratory Medicine (Sixth Edition) (pp. 1031-1049.e1034). Philadelphia: W.B. Saunders. Davis, T. J., Morris, M., & Drake, M. M. (2016). The moderation effect of mindfulness on the relationship between adult attachment and wellbeing. Personality and Individual Differences, 96, 115-121. doi:https://doi.org/10.1016/j.paid.2016.02.080 Delcroix, M., & Howard, L. (2015). Pulmonary arterial hypertension: the burden of disease and impact on quality of life. Eur Respir Rev, 24(138), 621-629. doi:10.1183/16000617.0063-2015 Fairchild, A. J., & Finney, S. J. (2006). Investigating Validity Evidence for the Experiences in Close Relationships-Revised Questionnaire. Educational and Psychological Measurement, 66(1), 116-135. doi:10.1177/0013164405278564 Farber, H. W., Badesch, D. B., Benza, R. L., Elliott, C. G., Frantz, R. P., McGoon, M. D., . . . Frost, A. E. (2018). Use of supplemental oxygen in patients with pulmonary arterial hypertension in REVEAL. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 37(8), 948. doi:10.1016/j.healun.2018.03.010 Forfia, P. R., & Trow, T. K. (2013). Diagnosis of pulmonary arterial hypertension. Clin Chest Med, 34(4), 665-681. doi:10.1016/j.ccm.2013.09.001 Frantz, R., Channick, R., Chin, K., Fischer, A., Gomberg-Maitland, M., Kleinman, L., . . . Badesch, D. (2016). Psychometric Validation of the PAH Symptoms and Impact (PAH-SYMPACT) Questionnaire: Results From the SYMPHONY Study. Chest, 150(4), 1160a-1160a. doi:10.1016/j.chest.2016.08.1269 Funabashi, S., Kataoka, M., Inami, T., Kikuchi, T., Yanagisawa, R., Ishiguro, C., . . . Satoh, T. (2017). Depressive Status in Patients With Chronic Thromboembolic Pulmonary Hypertension. Circ J, 81(7), 1051-1053. doi:10.1253/circj.CJ-17-0197 Galiè, N., Humbert, M., Vachiery, J.-L., Gibbs, S., Lang, I., Torbicki, A., . . . Hoeper, M. (2016). 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertensionThe Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). European Heart Journal, 37(1), 67-119. doi:10.1093/eurheartj/ehv317 Gall, H., Hoeper, M. M., Richter, M. J., Cacheris, W., Hinzmann, B., & Mayer, E. (2017). An epidemiological analysis of the burden of chronic thromboembolic pulmonary hypertension in the USA, Europe and Japan. European Respiratory Review, 26(143). doi:10.1183/16000617.0121-2016 Gao, Y. (2018). Pathophysiology of Pulmonary Hypertension. California : Morgan & Claypool, 2018. : San Rafael. Ghofrani , H.-A., D'Armini , A. M., Grimminger , F., Hoeper , M. M., Jansa , P., Kim , N. H., . . . Wang , C. (2013). Riociguat for the Treatment of Chronic Thromboembolic Pulmonary Hypertension. New England Journal of Medicine, 369(4), 319-329. doi:10.1056/NEJMoa1209657 Gopalan, D., Delcroix, M., & Held, M. (2017). Diagnosis of chronic thromboembolic pulmonary hypertension. Eur Respir Rev, 26(143). doi:10.1183/16000617.0108-2016 Guillevin, L., Armstrong, I., Aldrighetti, R., Howard, L. S., Ryftenius, H., Fischer, A., . . . Ferrari, P. (2013). Understanding the impact of pulmonary arterial hypertension on patients' and carers' lives. Eur Respir Rev, 22(130), 535-542. doi:10.1183/09059180.00005713 Harzheim, D., Klose, H., Pinado, F. P., Ehlken, N., Nagel, C., Fischer, C., . . . Guth, S. (2013). Anxiety and depression disorders in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension. Respir Res, 14, 104. doi:10.1186/1465-9921-14-104 Hayes, A. F. (2012). PROCESS: A versatile computational tool for observed variable mediation, moderation, and conditional process modeling [White paper]. In. Higasa, K., Ogawa, A., Terao, C., Shimizu, M., Kosugi, S., Yamada, R., . . . Matsuda, F. (2017). A burden of rare variants in BMPR2 and KCNK3 contributes to a risk of familial pulmonary arterial hypertension. BMC Pulm Med, 17(1), 57. doi:10.1186/s12890-017-0400-z Hoeper, M. M., Humbert, M., Souza, R., Idrees, M., Kawut, S. M., Sliwa-Hahnle, K., . . . Gibbs, J. S. (2016). A global view of pulmonary hypertension. Lancet Respir Med, 4(4), 306-322. doi:10.1016/s2213-2600(15)00543-3 Hoeper, M. M., Madani, M. M., Nakanishi, N., Meyer, B., Cebotari, S., & Rubin, L. J. (2014). Chronic thromboembolic pulmonary hypertension. The Lancet Respiratory Medicine, 2(7), 573-582. doi:10.1016/s2213-2600(14)70089-x Hoeper, M. M., McLaughlin, V. V., Dalaan, A. M. A., Satoh, T., & Galiè, N. (2016). Treatment of pulmonary hypertension. The Lancet Respiratory Medicine, 4(4), 323-336. doi:http://dx.doi.org/10.1016/S2213-2600(15)00542-1 Hsu, C.-H., Ho, W.-J., Huang, W.-C., Chiu, Y.-W., Hsu, T.-S., Kuo, P.-H., . . . Wang, K.-Y. (2014). 2014 Guidelines of Taiwan Society of Cardiology (TSOC) for the Management of Pulmonary Arterial Hypertension. Acta Cardiologica Sinica, 30(5), 401-444. Inami, T., Kataoka, M., Yanagisawa, R., Ishiguro, H., Shimura, N., Fukuda, K., . . . Satoh, T. (2016). Long-Term Outcomes After Percutaneous Transluminal Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension. Circulation, 134(24), 2030-2032. doi:10.1161/CIRCULATIONAHA.116.024201 Ivarsson, B., Rådegran, G., Hesselstrand, R., & Kjellström, B. (2017). Information, social support and coping in patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension—A nationwide population-based study. Patient Education and Counseling, 100(5), 936-942. doi:https://doi.org/10.1016/j.pec.2016.12.021 Jinyao, Y., Xiongzhao, Z., Auerbach, R. P., Gardiner, C. K., Lin, C., Yuping, W., & Shuqiao, Y. (2012). INSECURE ATTACHMENT AS A PREDICTOR OF DEPRESSIVE AND ANXIOUS SYMPTOMOLOGY. Depression and Anxiety, 29(9), 789-796. doi:10.1002/da.21953 Kamenskaya, O., Klinkova, A., Loginova, I., Chernyavskiy, A., Lomivorotov, V. V., & Karaskov, A. (2018). Factors affecting the quality of life before and after surgery in patients with chronic thromboembolic pulmonary hypertension. Qual Life Res, 27(3), 747-754. doi:10.1007/s11136-017-1712-4 Kim, E. J., Verma, S., Sahni, S., Athaanasiou, K., Patel, P., Kohn, N., & Talwar, A. (2013). Dyspnea, Depression, and Health Related Quality of Life [HRQOL] in Patients With Pulmonary Artery Hypertension [PAH]. Chest, 144(4), 864A-864A. doi:10.1378/chest.1703225 Lai, Y. C., Potoka, K. C., Champion, H. C., Mora, A. L., & Gladwin, M. T. (2014). Pulmonary arterial hypertension: the clinical syndrome. Circ Res, 115(1), 115-130. doi:10.1161/circresaha.115.301146 Leary, P. J., Kang, S., Kolb, T. M., Maron, B. A., Ralph, D. D., Rao, Y., . . . Zamanian, R. T. (2017). What’s in a side effect? The association between pulmonary vasodilator adverse drug events and clinical outcomes in patients with pulmonary arterial hypertension. International Journal of Cardiology, 240, 386-391. doi:10.1016/j.ijcard.2017.04.016 Leopold, J. A., & Maron, B. A. (2016). Molecular Mechanisms of Pulmonary Vascular Remodeling in Pulmonary Arterial Hypertension. Int J Mol Sci, 17(5). doi:10.3390/ijms17050761 Looper, K. J., Pierre, A., Dunkley, D. M., Sigal, J. J., & Langleben, D. (2009). Depressive symptoms in relation to physical functioning in pulmonary hypertension. Journal of Psychosomatic Research, 66(3), 221-225. doi:http://dx.doi.org/10.1016/j.jpsychores.2008.09.014 Lourenço, A. P., Fontoura, D., Henriques-Coelho, T., & Leite-Moreira, A. F. (2012). Current pathophysiological concepts and management of pulmonary hypertension. International Journal of Cardiology, 155(3), 350-361. doi:http://dx.doi.org/10.1016/j.ijcard.2011.05.066 Lowe, B., Grafe, K., Ufer, C., Kroenke, K., Grunig, E., Herzog, W., & Borst, M. M. (2004). Anxiety and depression in patients with pulmonary hypertension. Psychosom Med, 66(6), 831-836. doi:10.1097/01.psy.0000145593.37594.39 Mathai, S. C., Ghofrani, H. A., Mayer, E., Pepke-Zaba, J., Nikkho, S., & Simonneau, G. (2016). Quality of life in patients with chronic thromboembolic pulmonary hypertension. Eur Respir J, 48(2), 526-537. doi:10.1183/13993003.01626-2015 Matura, L. A., & Carroll, D. L. (2010). Human Responses to Pulmonary Arterial Hypertension: Review of the Literature. Journal of Cardiovascular Nursing, 25(5), 420-427. doi:10.1097/JCN.0b013e3181d25458 Matura, L. A., McDonough, A., & Carroll, D. L. (2016). Symptom Interference Severity and Health-Related Quality of Life in Pulmonary Arterial Hypertension. Journal of Pain and Symptom Management, 51(1), 25-32. doi:http://dx.doi.org/10.1016/j.jpainsymman.2015.07.012 McCollister, D., Shaffer, S., Badesch, D. B., Filusch, A., Hunsche, E., Schüler, R., . . . Peacock, A. (2016). Development of the Pulmonary Arterial Hypertension-Symptoms and Impact (PAH-SYMPACT®) questionnaire: a new patient-reported outcome instrument for PAH. Respir Res, 17(1), 72. doi:10.1186/s12931-016-0388-6 McCollister, D. H. (2011). Screening pulmonary hypertension patients for depression. International Journal of Clinical Practice, 65, 4-5. doi:10.1111/j.1742-1241.2011.02821.x McDonough, A., Matura, L. A., & Carroll, D. L. (2011). Symptom Experience of Pulmonary Arterial Hypertension Patients. Clinical Nursing Research, 20(2), 120-134. doi:doi:10.1177/1054773810391249 Mehta, S., Sastry, B. K., Souza, R., Torbicki, A., Ghofrani, H. A., Channick, R. N., . . . Sitbon, O. (2017). Macitentan Improves Health-Related Quality of Life for Patients With Pulmonary Arterial Hypertension: Results From the Randomized Controlled SERAPHIN Trial. Chest, 151(1), 106-118. doi:10.1016/j.chest.2016.08.1473 Merkes, M. (2010). Mindfulness-based stress reduction for people with chronic diseases. Australian Journal of Primary Health, 16(3), 200-210. Ogawa, A., Satoh, T., Tamura, Y., Fukuda, K., & Matsubara, H. (2017). Survival of Japanese Patients With Idiopathic/Heritable Pulmonary Arterial Hypertension. The American Journal of Cardiology, 119(9), 1479-1484. doi:http://doi.org/10.1016/j.amjcard.2017.01.015 Oudiz, R. J. (2016). Classification of Pulmonary Hypertension. Cardiol Clin, 34(3), 359-361. doi:https://doi.org/10.1016/j.ccl.2016.04.009 Paul, N. A., Stanton, S. J., Greeson, J. M., Smoski, M. J., & Wang, L. (2013). Psychological and neural mechanisms of trait mindfulness in reducing depression vulnerability. Social Cognitive and Affective Neuroscience, 8(1), 56-64. doi:10.1093/scan/nss070 Pfeuffer, E., Krannich, H., Halank, M., Wilkens, H., Kolb, P., Jany, B., & Held, M. (2017). Anxiety, Depression, and Health-Related QOL in Patients Diagnosed with PAH or CTEPH. Lung, 195(6), 759-768. doi:10.1007/s00408-017-0052-z Pietromonaco, P. R., Uchino, B., & Dunkel Schetter, C. (2013). Close relationship processes and health: Implications of attachment theory for health and disease. Health Psychology, 32(5), 499-513. doi:10.1037/a0029349 Rivers-Bowerman, M. D., Zener, R., Jaberi, A., de Perrot, M., Granton, J., Moriarty, J. M., & Tan, K. T. (2017). Balloon Pulmonary Angioplasty in Chronic Thromboembolic Pulmonary Hypertension: New Horizons in the Interventional Management of Pulmonary Embolism. Techniques in Vascular and Interventional Radiology, 20(3), 206-215. doi:https://doi.org/10.1053/j.tvir.2017.07.011 Robbins, I. M., Pugh, M. E., & Hemnes, A. R. (2017). Update on chronic thromboembolic pulmonary hypertension. Trends Cardiovasc Med, 27(1), 29-37. doi:10.1016/j.tcm.2016.05.010 Rubenfire, M., Lippo, G., Bodini, B. D., Blasi, F., Allegra, L., & Bossone, E. (2009). Evaluating Health-Related Quality of Life, Work Ability, and Disability in Pulmonary Arterial Hypertension: An Unmet Need. Chest, 136(2), 597-603. doi:https://doi.org/10.1378/chest.08-1260 Schellekens, M. P. J., Tamagawa, R., Labelle, L. E., Speca, M., Stephen, J., Drysdale, E., . . . Carlson, L. E. (2017). Mindfulness-Based Cancer Recovery (MBCR) versus Supportive Expressive Group Therapy (SET) for distressed breast cancer survivors: evaluating mindfulness and social support as mediators. J Behav Med, 40(3), 414-422. doi:10.1007/s10865-016-9799-6 Shafazand, S., Goldstein, M. K., Doyle, R. L., Hlatky, M. A., & Gould, M. K. (2004). Health-related quality of life in patients with pulmonary arterial hypertension. Chest, 126(5), 1452-1459. doi:10.1378/chest.126.5.1452 Skride, A., Sablinskis, K., Lejnieks, A., Rudzitis, A., & Lang, I. (2018). Characteristics and survival data from Latvian pulmonary hypertension registry: comparison of prospective pulmonary hypertension registries in Europe. Pulmonary Circulation, 8(3), 2045894018780521. doi:10.1177/2045894018780521 Somaini, G., Hasler, E. D., Saxer, S., Huber, L. C., Lichtblau, M., Speich, R., . . . Ulrich, S. (2016). Prevalence of Anxiety and Depression in Pulmonary Hypertension and Changes during Therapy. Respiration, 91(5), 359-366. doi:10.1159/000445805 Stevenson, J. C., Emerson, L. M., & Millings, A. (2017). The Relationship Between Adult Attachment Orientation and Mindfulness: a Systematic Review and Meta-analysis. Mindfulness (N Y), 8(6), 1438-1455. doi:10.1007/s12671-017-0733-y Suzuki, H., Sugimura, K., Tatebe, S., Aoki, T., & Shimokawa, H. (2016). Chronic thromboembolic pulmonary hypertension and schizophrenia. Int J Cardiol, 207, 363-364. doi:10.1016/j.ijcard.2016.01.010 Swetz, K. M., Shanafelt, T. D., Drozdowicz, L. B., Sloan, J. A., Novotny, P. J., Durst, L. A., . . . McGoon, M. D. (2012). Symptom burden, quality of life, and attitudes toward palliative care in patients with pulmonary arterial hypertension: Results from a cross-sectional patient survey. The Journal of Heart and Lung Transplantation, 31(10), 1102-1108. doi:http://dx.doi.org/10.1016/j.healun.2012.08.010 Tan, S.-B., Liam, C.-K., Pang, Y.-K., Leh-Ching Ng, D., Wong, T.-S., Wei-Shen Khoo, K., . . . Chai, C.-S. (2019). The Effect of 20-Minute Mindful Breathing on the Rapid Reduction of Dyspnea at Rest in Patients With Lung Diseases: A Randomized Controlled Trial. Journal of Pain and Symptom Management, 57(4), 802. doi:10.1016/j.jpainsymman.2019.01.009 Trammell, A. W., & Hemnes, A. R. (2015). Pathogenesis of Pulmonary Arterial Hypertension. In J. R. Klinger & R. P. Frantz (Eds.), Diagnosis and Management of Pulmonary Hypertension (pp. 37-65). New York, NY: Springer New York. van Dissel, A. C., Mulder, B. J., & Bouma, B. J. (2017). The Changing Landscape of Pulmonary Arterial Hypertension in the Adult with Congenital Heart Disease. J Clin Med, 6(4). doi:10.3390/jcm6040040 Vanhoof, M. M., Delcroix, M., Vandevelde, E., Denhaerynck, K., Wuyts, W., Belge, C., & Dobbels, F. (2014). Emotional symptoms and quality of life in patients with pulmonary arterial hypertension. J Heart Lung Transplant, 33(8), 800-808. doi:10.1016/j.healun.2014.04.003 Vanini, B., Grazioli, V., Sciortino, A., Pin, M., Merli, V. N., Celentano, A., . . . D’Armini, A. M. (2018). Neuropsychological outcomes after pulmonary endarterectomy using moderate hypothermia and periodic circulatory arrest. The Journal of Heart and Lung Transplantation. doi:https://doi.org/10.1016/j.healun.2018.02.007 Verma, S., Sahni, S., Vijayan, V., & Talwar, A. (2016). Depression in pulmonary arterial hypertension: An undertreated comorbidity. Lung India, 33(1), 58-63. doi:10.4103/0970-2113.173072 Wang, L.-Y., Lee, K.-T., Lin, C.-P., Hsu, L.-A., Wang, C.-L., Hsu, T.-S., & Ho, W.-J. (2017). Long-Term Survival of Patients with Pulmonary Arterial Hypertension at a Single Center in Taiwan. Acta Cardiologica Sinica, 33(5), 498. doi:10.6515/ACS20170612A White, J., Hopkins, R. O., Glissmeyer, E. W., Kitterman, N., & Elliott, C. G. (2006). Cognitive, emotional, and quality of life outcomes in patients with pulmonary arterial hypertension. Respir Res, 7, 55. doi:10.1186/1465-9921-7-55 Wryobeck, J. M., Lippo, G., McLaughlin, V., Riba, M., & Rubenfire, M. (2007). Psychosocial Aspects of Pulmonary Hypertension: A Review. Psychosomatics, 48(6), 467-475. doi:http://dx.doi.org/10.1176/appi.psy.48.6.467 Yorke, J., Deaton, C., Campbell, M., McGowen, L., Sephton, P., Kiely, D. G., & Armstrong, I. (2018). Symptom severity and its effect on health-related quality of life over time in patients with pulmonary hypertension: a multisite longitudinal cohort study. BMJ Open Respir Res, 5(1). doi:10.1136/bmjresp-2017-000263 | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/76504 | - |
dc.description.abstract | 背景:肺高壓是罕見疾病且由於慢性症狀困擾,例如呼吸短促而長期影響病人的情緒的困擾。國外研究發現有憂鬱傾向的肺高壓病患整體存活率也較低。國內缺乏對於憂鬱的現況和其影響因素進行探討,因此本研究將進行此議題的調查。
目的:本研究目的在探究肺高壓病患憂鬱和其他社會心理因素的相關性。 方法:採橫斷式研究法(cross-sectional study),對象包括20歲以上第一型和第四型的肺高壓病患,以及相同性別年齡配適之健康受試族群作為控制組。透過結構式問卷進行資料收集,包括:「基本資料量表」、「貝氏憂鬱量表」、「肺動脈高壓症狀干擾量表」、「親密關係量表」與「止觀覺察注意量表」。 結果:本研究結果發現肺高壓組相較健康組的憂鬱程度及肺高壓症狀得分顯著較高,且達臨床憂鬱症狀的程度的比例: 肺高壓組有20.8%,而健康組只有2.8%。影響憂鬱的預測因子中,肺高壓組症狀越嚴重者與有工作者,憂鬱程度較高,健康組則是有伴侶者憂鬱程度較高。親密關係中的焦慮依附同時為肺高壓和健康組憂鬱的影響因素。路徑分析結果發現肺高壓組在控制職業因素下,正念覺察程度越高能降低症狀困擾造成的影響,進而降低憂鬱程度( 正念→肺高壓症狀→憂鬱);而健康組於控制婚姻因素後,正念覺察能降低焦慮依附的程度而降低憂鬱程度 (正念→焦慮依附→憂鬱 )。 結論:肺高壓組預測憂鬱的主要因素為肺高壓症狀困擾、職業狀態與親密關係中焦慮依附。另外正念覺察能透過緩解肺高壓症狀進而降低憂鬱症狀。建議未來推展預防肺高壓病患憂鬱之措施,包含門診症狀與身心狀態簡易篩檢,同時提供正念訓練提升症狀的自我照顧,以及促進安全依附親密關係的心理諮商。 | zh_TW |
dc.description.abstract | Background: Pulmonary hypertension (PH) is a rare disease and its chronic symptom distress such as short of breath influences their emotional distress. The study found that the PH patients with depression are the high-risk group for lower survival rates. However, there is a lack of study in Taiwan examining depression and its associated factors in Taiwan. Therefore, this study emphasizes in this research issue.
Purpose/Objectives: This study aimed to examine the depression among PH patients and its correlation with psychological factors. Methods: This study adopted the cross-sectional correlation design. The inclusion criteria of PH patients are that they are diagnosed as type 1 and type 4 pulmonary hypertension, and are aged at least 20 years old. The age-match healthy subjects are also recruited from community as control group. Data were collected by using structured questionnaires including “personal characteristics questionnaire,” “Beck Depression Inventory-II (BDI),”“Pulmonary Arterial Hypertension-Symptoms and Impact questionnaire (PAH-SYMPACT),”“The Experiences in Close Relationships-Revised (ECR-R),” and “Mindful Attention Awareness Scale(MAAS).” Results: This study found that in comparison with healthy control group, PH group appeared to have higher levels of depression and the clinical depression cases (20.8% vs 2.8%). In PH group, higher depression levels were associated with pulmonary arterial hypertension symptoms and were occurred in those with having a job. Differently, for control group, those with married endorsed with higher scores of depression. For both PH and control groups, higher scores of anxiety attachment style were associated with higher depression levels. The mediator analysis showed that in PH group, after controlling with job factor, higher mindfulness could reduce depression through its reducing the pulmonary arterial hypertension symptoms ( mindfulness→PH symptoms→depression). Differently, in control group, after controlling marital status, mindfulness could reduce depression by its reducing anxious attachment style in close relationship ( mindfulness→anxious attachment style→depression). Conclusion: Depression of PH patients is mainly associated with physical symptom distress, burden from job and anxious attachment style in close relationship. Moreover, mindfulness can reduce depression by its impacts on decreasing physical symptoms. Accordingly, the strategies for PAH depression program include screening depression status in outpatient department, providing mindfulness skill training to increase the capacity of self-care, and counseling to increase the secure attachment style in close relationship. | en |
dc.description.provenance | Made available in DSpace on 2021-07-09T15:53:24Z (GMT). No. of bitstreams: 1 ntu-108-R04426018-1.pdf: 1627895 bytes, checksum: 243455f4fb685d245881a87c47146e84 (MD5) Previous issue date: 2019 | en |
dc.description.tableofcontents | 誌 謝 I
中文摘要 II ABSTRACT IV 目 錄 VI 圖目錄 IX 表目錄 X 第一章 緒論 11 第一節 研究背景與動機 11 第二節 研究目的 13 第三節 名詞解釋 13 第二章 文獻回顧 14 第一節 肺高壓近期研究概況 14 一、定義與分類 14 二、病生理機轉 17 三、臨床表徵 18 四、診斷方法 19 五、治療進展 21 第二節 肺高壓與憂鬱相關研究結果 23 一、肺高壓與憂鬱研究現況 23 二、疾病與治療對憂鬱的影響 23 三、生活品質對憂鬱的影響 25 四、社會心理層面對憂鬱的影響 26 第三章 研究方法與步驟 29 第一節 研究架構 29 第二節 研究設計 30 第三節 研究對象 30 第四節 研究假設 31 第五節 研究工具 31 第六節 研究步驟 33 第七節 資料整理與分析 34 第八節 研究對象權益維護 35 第四章 研究結果 36 第一節、肺高壓病患與健康受試者基本屬性分析 36 第二節、 第一型與第四型肺高壓病患疾病相關屬性分析 38 第三節、肺高壓病患與健康族群於憂鬱程度、症狀、親密關係與正念程度的比較 41 第四節、影響肺高壓病患及健康族群憂鬱程度的相關因子 42 第五章、討論 47 第一節、肺高壓族群人口學與疾病特性之差異 47 第二節、肺高壓與健康族群憂鬱程度之差異 48 第三節、影響肺高壓組與健康組憂鬱的主要相關因子 48 第四節、肺高壓族群其正念於肺高壓症狀和憂鬱關係中之角色 49 第六章、結論與建議 51 第一節、 研究結論 51 第二節、 研究限制 52 第三節、 研究應用與建議 52 參考文獻 53 中文文獻 53 英文文獻 53 附 錄 61 附錄一、資本資料表 61 附錄二、貝氏憂鬱量表 64 附錄三、PAH-SYMPACT肺動脈高壓症狀干擾量表 67 附錄四、親密關係量表 69 附錄五、MAAS止觀覺察注意量表 70 | |
dc.language.iso | zh-TW | |
dc.title | 肺高壓病患憂鬱程度及其影響因素 | zh_TW |
dc.title | Depression and its related factors in patients with pulmonary hypertension | en |
dc.type | Thesis | |
dc.date.schoolyear | 107-2 | |
dc.description.degree | 碩士 | |
dc.contributor.oralexamcommittee | 徐紹勛(Hsao-Hsun Hsu),林彥宏(Yen-Hung Lin) | |
dc.subject.keyword | 肺高壓,憂鬱,身體症狀困擾,正念,親密關係的依附型態, | zh_TW |
dc.subject.keyword | pulmonary hypertension,depression,physical symptom distress,attachment styles in close relationship,mindfulness, | en |
dc.relation.page | 71 | |
dc.identifier.doi | 10.6342/NTU201903750 | |
dc.rights.note | 同意授權(全球公開) | |
dc.date.accepted | 2019-08-15 | |
dc.contributor.author-college | 醫學院 | zh_TW |
dc.contributor.author-dept | 護理學研究所 | zh_TW |
dc.date.embargo-lift | 2022-08-28 | - |
顯示於系所單位: | 護理學系所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-108-R04426018-1.pdf | 1.59 MB | Adobe PDF | 檢視/開啟 |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。